The global contact and intraocular lenses market is witnessing robust expansion owing to the increasing prevalence of cataracts, refractive errors, and age-related vision disorders across the world. The market was valued at US$ 11.6 Bn in 2023 and is projected to reach US$ 22.9 Bn by the end of 2034, advancing at a CAGR of 6.4% from 2024 to 2034.

Growing awareness regarding vision correction procedures, rising demand for minimally invasive ophthalmic surgeries, and continuous innovations in premium lens technologies are collectively accelerating industry growth. Contact lenses and intraocular lenses (IOLs) are increasingly being adopted for correcting visual impairments such as myopia, hyperopia, presbyopia, and astigmatism, thereby improving quality of life for millions of patients worldwide.

Analyst Viewpoint

The rise in cataract cases globally remains one of the most significant drivers of the contact and intraocular lenses market. Cataracts continue to be among the leading causes of blindness and vision impairment, particularly among the aging population. As cataract surgeries become more accessible and technologically advanced, the demand for intraocular lenses is increasing substantially.

Contact and intraocular lenses play a critical role in correcting vision problems related to far-sightedness, near-sightedness, and astigmatism. Specialized intraocular lenses such as phakic intraocular lenses (PIOLs) are also gaining traction among ophthalmologists for patients where preservation of the natural crystalline lens is preferred.

Market players are increasingly focusing on multifocal vision correction technologies. Companies are developing advanced spiral lenses capable of delivering benefits similar to progressive lenses while minimizing visual distortion. Such technological innovations are expected to intensify competition and open new growth opportunities within the market.

Additionally, governments and non-government organizations worldwide are implementing programs aimed at eliminating preventable blindness and reducing cataract-related vision loss, thereby further supporting market expansion.

Growing Burden of Ocular Disorders Boosting Market Growth

The rising incidence of ocular disorders is significantly contributing to the adoption of contact and intraocular lenses. Conditions such as hyperopia, myopia, presbyopia, astigmatism, keratoconus, and aniseikonia are becoming increasingly common due to aging demographics, excessive digital screen exposure, and changing lifestyles.

Contact lenses have emerged as an effective solution for correcting refractive errors while offering cosmetic and lifestyle advantages over conventional eyeglasses. Similarly, intraocular lenses are becoming indispensable during cataract surgeries and refractive lens exchange procedures.

According to the 2022 Vision Index report, nearly 81% of myopic patients experience difficulty seeing distant objects. The report further highlights that short-sightedness was among the most common diagnoses among Australians who underwent eye examinations in 2022. Such statistics indicate the growing global demand for advanced vision correction solutions.

However, despite favorable market dynamics, lack of awareness regarding premium intraocular lens products and inadequate reimbursement policies continue to restrain market penetration in certain regions. For instance, healthcare insurance coverage in India often excludes premium intraocular lenses, prescribed eyeglasses, and eye drops, creating affordability concerns among patients.

Increase in Cataract Surgeries Fueling Demand

The growing number of cataract surgeries worldwide is a major factor propelling the contact and intraocular lenses market. Cataract surgery remains one of the most commonly performed ophthalmic procedures globally, especially among elderly populations.

According to the National Programme for Control of Blindness and Visual Impairment (NPCBVI), approximately 83,44,824 cataract surgeries were performed in India during FY 2022-23 alone. This massive volume demonstrates the increasing burden of cataracts and the corresponding demand for intraocular lenses.

Research published in Scientific Reports in January 2022 indicated that cataracts and blepharoptosis are among the most common ophthalmic disorders affecting older adults in South Korea. The study reported cataract prevalence rates reaching nearly 15% among middle-aged and elderly individuals.

As healthcare systems continue prioritizing vision restoration and cataract elimination programs, the demand for advanced intraocular lenses, particularly multifocal and toric lenses, is expected to rise considerably during the forecast period.

Government and NGO Initiatives Accelerating Adoption

Several government and non-government organizations are launching initiatives aimed at reducing preventable blindness caused by cataracts and refractive disorders. These initiatives are positively influencing the demand for contact lenses and intraocular implants globally.

One of the most prominent initiatives is the International Agency for the Prevention of Blindness (IAPB)’s Vision 2020 program, which seeks to eliminate avoidable blindness worldwide. The initiative involves participation from governments across more than 50 countries and includes eye screening camps, reimbursement support, awareness programs, and improved access to ophthalmic treatment.

In India, the Union Health Ministry introduced the “Netra Jyoti Abhiyan” campaign to accelerate cataract surgeries and clear surgical backlogs by assigning annual surgery targets to states and union territories.

Such initiatives are increasing patient awareness regarding vision correction procedures and enhancing accessibility to ophthalmic healthcare services, thereby contributing significantly to market growth.

Technological Advancements Transforming the Industry

Technological innovation is reshaping the contact and intraocular lenses industry. Companies are investing heavily in research and development to introduce advanced lens materials, precision surgical systems, and premium vision correction products.

The adoption of silicone hydrogel materials is growing due to their superior oxygen permeability and enhanced comfort. In the intraocular lens segment, hydrophobic and hydrophilic acrylic lenses continue to gain popularity owing to improved biocompatibility and visual outcomes.

Manufacturers are also focusing on extended depth-of-focus (EDOF) intraocular lenses that improve both near and intermediate vision while reducing glare and halos.

For instance, in January 2021, Alcon Inc. launched the AcrySof IQ Vivity IOL, a non-diffractive extended depth-of-focus lens utilizing proprietary X-WAVE technology to improve visual performance.

Similarly, in January 2023, Centricity Vision Inc. introduced the ZEPTO IOL Positioning System to enhance cataract surgery precision and improve patient outcomes.

North America Dominates the Global Market

North America accounted for the largest share of the contact and intraocular lenses market in 2023 and is expected to maintain its dominance throughout the forecast period.

The region’s leadership is attributed to the high prevalence of presbyopia and vision impairment, advanced healthcare infrastructure, favorable reimbursement frameworks, and strong presence of leading ophthalmic companies.

According to Ophthalmology Management data updated in May 2022, the U.S. had nearly 128 million presbyopic individuals. This number is expected to rise further as millennials enter their 30s and begin experiencing age-related vision changes.

Additionally, NVision Centers reported that nearly 12 million Americans aged 40 and above were living with vision impairment in 2022. In Canada, approximately 1.2 million individuals were affected by vision loss in 2021, while nearly 8 million Canadians were suffering from eye conditions that could potentially lead to blindness.

Continuous product launches by key players are also supporting regional market expansion. In October 2023, Bausch + Lomb launched enVista Aspire monofocal and toric intraocular lenses in the U.S. market, expanding its ophthalmic product portfolio.

Competitive Landscape

The contact and intraocular lenses market is highly competitive, with leading companies focusing on product innovation, strategic collaborations, acquisitions, and global expansion.

In April 2022, Rayner Surgical Group Limited collaborated with Aston University to develop next-generation lenses capable of providing patients with enhanced full-range vision quality.

In November 2023, Ophtec B.V. launched Precizon Go, a hybrid acrylic intraocular lens designed to improve both distance and intermediate vision.

Major companies operating in the global market include Johnson & Johnson, Alcon Inc., Bausch + Lomb, Carl Zeiss Meditec AG, Hoya Corporation, Essilor International, NIDEK CO., LTD., Rayner Surgical Group Limited, Ophtec B.V., and Omni Lens Pvt. Ltd..

Future Outlook

The future of the contact and intraocular lenses market appears highly promising as rising cataract prevalence, growing awareness regarding vision correction, and advancements in ophthalmic technologies continue to drive industry demand.

Increasing adoption of premium multifocal and toric lenses, coupled with expansion of cataract elimination initiatives globally, is expected to create lucrative opportunities for manufacturers over the coming decade.

With continuous innovation in lens materials, surgical precision systems, and personalized vision correction solutions, the global contact and intraocular lenses market is poised for sustained growth through 2034.